Commonwealth Equity Services’s Genomic Health, Inc. GHDX Stock Holding History

Commonwealth Equity Services’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,702	Closed	-$251K	–	2985
2019 Q3	$251K	Buy	+3,702	New	+$254K	﹤0.01%	2385
2019 Q2	–	Sell	-3,025	Closed	-$211K	–	2845
2019 Q1	$211K	Buy	+3,025	New	+$224K	﹤0.01%	2429
2018 Q4	–	Sell	-3,356	Closed	-$235K	–	2867
2018 Q3	$235K	Buy	+3,356	New	+$196K	﹤0.01%	2377

Commonwealth Equity Services's GHDX Position: Q4 2019 in Review

Commonwealth Equity Services sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 3,702 shares — an estimated $251K sold.

Commonwealth Equity Services first reported a position in GHDX in Q3 2018 and held it in 3 quarters. The position peaked at $251K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Commonwealth Equity Services reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Commonwealth Equity Services sold 3,702 Genomic Health, Inc. shares in Q4 2019, an estimated $251K.
Commonwealth Equity Services first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 3 quarters.
Commonwealth Equity Services's Genomic Health, Inc. position peaked at $251K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Commonwealth Equity Services's 13F filing for Q4 2019, filed 5 Feb 2020.